open.michigan

Author(s): Louis D'Alecy, D.M.D., Ph.D., 2009

License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution-Non-commercial-Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation key on the following slide provides information about how you may share and adapt this material.

Copyright holders of content included in this material should contact open.michigan@umich.edu with any questions, corrections, or clarification regarding the use of content.

For more information about how to cite these materials visit http://open.umich.edu/education/about/terms-of-use.

Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition.

Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.

MUNIVERSITY OF MICHIGAN

CC BY NC SA

# Citation Key

for more information see: http://open.umich.edu/wiki/CitationPolicy

## Use + Share + Adapt

{ Content the copyright holder, author, or law permits you to use, share and adapt. }

- **PD-GOV** Public Domain – Government: Works that are produced by the U.S. Government. (USC 17 § 105)
- **PD-EXP** Public Domain – Expired: Works that are no longer protected due to an expired copyright term.
- **PD-SELF** Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain.
- **ZERO** Creative Commons – Zero Waiver
- **BY** Creative Commons – Attribution License
- **BY-SA** Creative Commons – Attribution Share Alike License
- **BY-NC** Creative Commons – Attribution Noncommercial License
- **BY-NC-SA** Creative Commons – Attribution Noncommercial Share Alike License
- **GNU-FDL** GNU – Free Documentation License

## Make Your Own Assessment

{ Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. }

- **PD-INEL** Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (USC 17 § 102(b)) *laws in your jurisdiction may differ

{ Content Open.Michigan has used under a Fair Use determination. }

- **FAIR USE** Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (USC 17 § 107) *laws in your jurisdiction may differ

Our determination **DOES NOT** mean that all uses of this 3rd-party content are Fair Uses and we **DO NOT** guarantee that your use of the content is Fair.

To use this content you should do your own independent analysis to determine whether or not your use will be Fair.

3

M2 Mini Review
Summer 2008
Chapter 9 Lilly

With flash backs to Mohrman and Heller
Pathophysiology of Heart Failure
Congestive HF = CO ≡ Demand
= ↓ CO &amp;/or ↑ Demand

Louis G. D’ Alecy, Professor of Physiology

# Heart Failure Outline

1) Normal Control of Stroke Volume
a) Contractility
b) Preload
c) Afterload

2) Pathophysiology
a) Systolic Dysfunction
b) Diastolic Dysfunction
c) Right-Sided Heart Failure
d) Compensatory Mechanisms

4

# Requirements for Effective Cardiac Pumping

1 Synchronized not arrhythmic
2 Valves open fully not stenotic
3 Valves don't leak not insufficient or regurgitant
4 Forceful = not failing
5 Must fill Not "dry"

5

![img-0.jpeg](img-0.jpeg)

Fig. 3.14
Lilly p 61

2 Pumps
-in series
-Interact
-Preload
-Afterload

PD-INEL Lilly Pg. 61

Interaction RV &amp; LV (e.g.)

If RV in failure inadequate blood gets to LV for adequate LV preload &amp; LV output goes ↓.

If LV in failure inadequate blood gets removed from lungs and RV and excess afterload to RV ↓ output &amp; ↑ pulmonary edema.

7

# Lilly Table 9.1 Definitions

**Preload** - The ventricular wall tension at the end of diastole.

**Afterload** -- The ventricular wall tension during contraction; the resistance that must be overcome for the ventricle to eject its contents. Approximated by systolic ventricular or arterial pressure.

**Contractility** -- Property of heart muscle that accounts for changes in strength of contraction independent of preload and afterload.

8

![img-1.jpeg](img-1.jpeg)

PD-INEL

Source Undetermined

![img-2.jpeg](img-2.jpeg)
Fig 9.5

PD-INEL

Source Undetermined

![img-3.jpeg](img-3.jpeg)
Decreased SV with Systolic Dysfunction
Fig 9.7

PD-INEL

Source Undetermined

![img-4.jpeg](img-4.jpeg)
A
Pressure (mm Hg)
Normally:
Increased preload increases
stroke volume
ESV
Figure 9.5
Volume (ml) (Preload)

PD-INEL

Source Undetermined

![img-5.jpeg](img-5.jpeg)

PD-INEL

Source Undetermined

![img-6.jpeg](img-6.jpeg)
Fig 9.3

#

PD-INEL

Source Undetermined

![img-7.jpeg](img-7.jpeg)
15

![img-8.jpeg](img-8.jpeg)
Fig 9.5

PD-INEL

Source Undetermined

17

Inotropic state or
End-diastolic Pressure or
Arterial Pressure or LV stress

Contractility
Preload
Afterload

Heart rate
Stroke volume

LaPlace Relationship

CARDIAC OUTPUT

©
PD-INEL
Source Undetermined

systolic ejection. Wall stress $(\sigma)$, like pressure, is expressed as force per unit area, and for the left ventricle, may be estimated from the LaPlace relation for a hollow sphere:

$$
\sigma = \frac{P \cdot r}{2h}
$$

Pressure X radius
2 X thickness

in which P is ventricular pressure, r is ventricular chamber radius, and h is ventricular wall thickness. In general, a useful mea

Page 229 Lilly
Hypertrophy: not beat to beat.
PD-THEL Lilly Pg. 229

# From Surgery: Scientific Principles and Practice
Ed. By Greenfield, Mulholland, Oldham, Zelenock, and Lillemoe

# Laplace Law

$$
\mathrm{CWS} = \frac{(\mathrm{Pb})}{\mathrm{h}} \left(1 - \frac{\mathrm{b}^2}{2\mathrm{a}^2} - \frac{\mathrm{h}}{2\mathrm{b}} + \frac{\mathrm{h}}{8\mathrm{a}^2}\right)
$$

where:

$\mathrm{CWS} = \text{circumferential wall stress in dynes/cm}^2 \times 10^3$;

$\mathrm{P} = \text{left ventricular pressure in dynes/cm}^2$; $\mathrm{a}$ and $\mathrm{b}$

$= \text{major and minor semiaxes, respectively, in cm}$;

$\mathrm{h} = \text{left ventricular wall thickness in cm}$

PD-INEL Surgery: Scientific Principles and Practice Ed., Greenfield, Mulholland, Oldham, Zelenock, and Lillemoe

![img-9.jpeg](img-9.jpeg)

$$
T = P \times r
$$

Tension = Press X radius

“COST”

$$
T = P \cdot r
$$

2T = P \times 2r
$$

50T = 50P \times r

$$
50T = 50P \times r
$$

PD-INEL

Source Undetermined

$$
T = P \times r
$$

Tension = Press X radius
"COST"

$$
1T = P \times 1r
$$

![img-0.jpeg](img-0.jpeg)

PCWP
or
LVEDP

$$
2T = P \times 2r
$$

As ventricle fills during diastole
the volume increases, tension doubles,
with little increase in pressure

PD-INEL
Source Undetermined

$$
T = P \times r
$$

Tension = Press X radius

"COST"

# Isovolumetric contraction Increases T and P

![img-1.jpeg](img-1.jpeg)

PD-INEL

Source Undetermined

![img-2.jpeg](img-2.jpeg)

$$
T = P \times r
$$

Tension = Press X radius

“COST”

PD-INEL

Source Undetermined

50T = 50P x r

25P

2r

50T = 25P x 2r

50T = 25P x 2r

# Left ventricle pressure-volume loop

![img-3.jpeg](img-3.jpeg)

50P (Systolic)
LaPlace
25P (Diastolic)

Fig. 9.4

PD-INEL

Source Undetermined

# Pathophysiology of HF

CO fails to meet demand because:

1) SYSTOLIC DYSFUNCTION
a) Impaired ventricular contractile function
b) Increased afterload

2) DIASTOLIC DYSFUNCTION
a) Impaired ventricular filling

3) COMPENSATORY MECHANISMS
a) Frank-Starling
b) Hypertrophy
c) Neurohumoral

25

PD-INEL

# Impaired Contractility

1. Myocardial infarction
2. Transient myocardial ischemia
3. Chronic volume overload
a. mitral regurgitation
b. aortic regurgitation
4. Dilated cardiomyopathy

# Afterload (Pressure Overload)

1. Aortic stenosis
2. Uncontrolled hypertension

# Reflexes

# Systolic Dysfunction

# Left-sided Heart Failure

Fig 9.6 Top

27

PD-INEL

Source Undetermined

27

Impaired Contractile function

1. Myocardial infarction
2. Transient myocardial ischemia
3. Chronic volume overload
a. mitral regurgitation
b. aortic regurgitation
4. Dilated cardiomyopathy

↑↑ Afterload (Pressure Overload)

1. Aortic stenosis
2. Uncontrolled hypertension

Systolic Dysfunction

↓

Left-sided Heart Failure

↑

Diastolic Dysfunction

2/3

1/3

Impaired Ventricular Relaxation

1. Left ventricular hypertrophy
2. Hypertrophic cardiomyopathy
3. Restrictive cardiomyopathy
4. Transient myocardial ischemia

Obstruction of Left Ventricular Filling

1. Mitral stenosis
2. Pericardial constriction or tamponade

28

PD-INEL

Source Undetermined

Left-sided Heart Failure

Diastolic Dysfunction

Fig 9.6 Bottom

Stiffness

"Chronic" Acute

Impaired Ventricular Relaxation

1. Left ventricular hypertrophy
2. Hypertrophic cardiomyopathy
3. Restrictive cardiomyopathy
4. Transient myocardial ischemia

Obstruction of Left Ventricular Filling

1. Mitral stenosis
2. Pericardial constriction or tamponade

![img-4.jpeg](img-4.jpeg)
B Decreased SV with Diastolic Dysfunction
Increased stiffness
Decreased Compliance
Fig 9.7 B

PD-INEL

Source Undetermined

# Right-Sided Heart Failure

## TABLE 9.2. Examples of Conditions That Cause Right-Sided Heart Failure

- Cardiac causes
- Left-sided heart failure
- Pulmonic valve stenosis
- Right ventricular infarction
- Parenchymal pulmonary disease
- Chronic obstructive pulmonary disease
- Interstitial lung disease (e.g., sarcoidosis)
- Adult respiratory distress syndrome
- Chronic lung infection or bronchiectasis
- Pulmonary vascular disease
- Pulmonary embolism
- Primary pulmonary hypertension

PD-INEL
Source Undetermined

![img-5.jpeg](img-5.jpeg)

CARDIAC OUTPUT

+ AFTERLOAD
+ CONTRACTILITY
+ HEART RATE **limited

+ AFTERLOAD
+ CONTRACTILITY
+ HEART RATE

PRELOAD **limited

PD-INEL

Source Undetermined

32

Heart Failure
COMPENSATORY MECHANISMS
or failing compensatory mechanisms!

Frank-Starling
Hypertrophy
Neurohumoral

![img-6.jpeg](img-6.jpeg)
Fig. 9.8

#

PD-INEL

Source Undetermined

![img-7.jpeg](img-7.jpeg)
Fig. 9.9

PD-INEL

Source Undetermined

Peripheral edema and pulmonary congestion

35

Decreased Cardiac Output

![img-8.jpeg](img-8.jpeg)

Decreased CO ..decreased MAP...Baroreceptor Reflex !!!

PD-INEL

Source Undetermined

# Baroreceptor Reflex

36

PD-THEL

Source Undetermined

![img-9.jpeg](img-9.jpeg)

![img-10.jpeg](img-10.jpeg)

![img-11.jpeg](img-11.jpeg)

PD-INEL

Source Undetermined

Peripheral edema and pulmonary congestion

TABLE 9-4 COMPARISON OF CARDIOVASCULAR FUNCTION IN A NORMAL PERSON AND A PATIENT WITH MODERATE-TO-SEVERE CONGESTIVE HEART FAILURE (CHF) AT REST AND AT MAXIMAL (MAX) EXERCISE

|   | CO
(LITERS/MIN) | HR
(BEATS/MIN) | SV
(ML) | MAP
(MM HG) | VO₂
(ML O₂/MIN) | A-VO₂
(ML O₂/100 ML)  |
| --- | --- | --- | --- | --- | --- | --- |
|  Normal (Rest) | 5.6 | 70 | 80 | 95 | 220 | 4.0  |
|  Normal (Max) | 18.0 | 170 | 106 | 120 | 2500 | 13.9  |
|  CHF (Rest) | 4.0 | 80 | 50 | 90 | 220 | 5.5  |
|  CHF (Max) | 6.0 | 120 | 50 | 85 | 780 | 13.0  |

CO, cardiac output; HR, heart rate; SV, stroke volume; MAP, mean arterial pressure; VO₂, whole-body oxygen consumption; A-VO₂, arterial-venous oxygen difference. VO₂ is calculated from the product of CO and A-VO₂, after the units for CO are converted to mL/min and the units for A-VO₂ are converted to mL O₂/mL blood.

PD-ENEL Source Undetermined

# TABLE 9.3. Factors that may Precipitate Symptoms in Compensated Heart Failure

Increase **metabolic demands**

- Fever
- Infection
- Anemia
- Tachycardia
- Hyperthyroidism
- Pregnancy

Things that require an increase in cardiac output.

39

PD-INEL

Source Undetermined

40

# TABLE 9.3. Factors that may Precipitate Symptoms in Compensated Heart Failure

- Increased circulating volume (increased preload)
- Excessive sodium content in diet
- Excessive fluid administration
- Renal failure
- Conditions that increase afterload
- Uncontrolled hypertension
- Pulmonary embolism (increased right ventricular afterload)
- Conditions that impair contractility
- Negative inotropic medications
- Myocardial ischemia or infarction
- Ethanol ingestion
- Failure to take prescribed heart failure medications
- Excessively slow heart rate

e.g.
Beta blk.
Isoflurane
Thiopental

PD-INEL
Source Undetermined

# Coming Attractions: what to do!

Fig 9.10

![img-0.jpeg](img-0.jpeg)

PD-INE

Source Undetermined

# HF-Evidence Based Therapies

1) ACE inhibitors
2) ARB’s (angiotensin receptor blockers)
3) Beta-blockers
4) Aldosterone antagonists
5) Anticoagulants for Atrial fibrillation
6) Implantable cardioverter (ICD)
7) Cardiac resynchronization (CRT)

42

# Additional Source Information

for more information see: http://open.umich.edu/wiki/CitationPolicy

Slide 6: Lilly Pg. 61

Slide 9: Source Undetermined

Slide 10: Source Undetermined

Slide 11: Source Undetermined

Slide 12: Source Undetermined

Slide 13: Source Undetermined

Slide 14: Source Undetermined

Slide 15: Source Undetermined

Slide 16: Source Undetermined

Slide 17: Source Undetermined

Slide 18: Lilly Pg. 229

Slide 19: Surgery: Scientific Principles and Practice Ed., Greenfield, Mulholland, Oldham, Zelenock, and Lillemoe

Slide 20: Source Undetermined

Slide 21: Source Undetermined

Slide 22: Source Undetermined

Slide 23: Source Undetermined

Slide 24: Source Undetermined

Slide 26: Source Undetermined

Slide 27: Source Undetermined

Slide 28: Source Undetermined

Slide 29: Source Undetermined

Slide 30: Source Undetermined

Slide 31: Source Undetermined

Slide 33: Source Undetermined

Slide 34: Source Undetermined

Slide 35: Source Undetermined

Slide 36: Source Undetermined

Slide 37: Source Undetermined

Slide 38: Source Undetermined

Slide 39: Source Undetermined

Slide 40: Source Undetermined

Slide 41: Source Undetermined